West Pharmaceutical Services Q4 FY25: where the revenue came from and where it went
The whole income statement of West Pharmaceutical Services for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 17, 2026
Revenue$0.81B
+8% year over year
Gross profit$0.30B
38% margin
Operating profit$0.16B
19% margin
Net profit$0.13B
16% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.81 | 100% | +8% |
| Proprietary products | 0.66 | 82% | +8% |
| Contract manufactured | 0.14 | 18% | +6% |
| Cost of revenue | −0.50 | 62% | |
| Gross profit | 0.30 | 38% margin | +1pp |
| R&D | −0.02 | 3% | +0pp |
| SG&A | −0.11 | 13% | +2pp |
| Other | −0.02 | 2% | +0pp |
| Operating profit | 0.16 | 19% margin | −2pp |
| Other income, net | 0.01 | ||
| Tax | −0.03 | ||
| Net profit | 0.13 | 16% margin | −1pp |
303 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest